Pelthos Therapeutics to acquire Castle Creek Biosciences in gene therapy merger backed by $57.5m financing
Read More Pharma Industry News Breakthrough Parkinson’s research: Annovis says buntanetap improved cognition in patients with amyloid co-pathology Discover why new biomarker data suggests amyloid co-pathology may accelerate cognitive decline in Parkinson’s and how buntanetap could help change treatment planning. bySoujanya RaviNovember 17, 2025